| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,110 |
2,081 |
$315K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,423 |
1,421 |
$206K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
889 |
878 |
$128K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
623 |
621 |
$92K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
505 |
496 |
$67K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,518 |
3,452 |
$21K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
87 |
87 |
$12K |
| S9083 |
Global fee urgent care centers |
40 |
38 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
291 |
289 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
224 |
224 |
$619.89 |
| 87808 |
|
12 |
12 |
$160.00 |
| 81002 |
|
134 |
134 |
$160.00 |
| 87807 |
|
16 |
16 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
25 |
25 |
$0.00 |
| A9150 |
Non-prescription drugs |
13 |
12 |
$0.00 |
| 87905 |
|
12 |
12 |
$0.00 |
| 73630 |
|
13 |
13 |
$0.00 |
| 81025 |
|
24 |
24 |
$0.00 |